KPV
Also known as: Lys-Pro-Val, Alpha-MSH derivative
Three-amino-acid fragment of alpha-melanocyte-stimulating hormone, studied for inflammation in the gut and skin.
Evidence
Preclinical
FDA status
Not FDA-approved
Source
Synthetic tripeptide derived from α-MSH
Overview
Three-amino-acid fragment of alpha-melanocyte-stimulating hormone, studied for inflammation in the gut and skin.
Mechanism of Action
Reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), modulates immune response without direct antimicrobial killing, calms excessive inflammation, supports gut barrier function.
What research has looked at
Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.
- Inflammation in animal models of colitis
- Reduces inflammatory cytokines
- Gut lining in animal models
- No immune suppression
- Combination with other peptides (lab studies)
- Tolerability (little human data)
Researched for
Research topics, not approved uses.
How Gabriel approaches peptides
Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. KPV isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.
Research & Evidence
Preclinical studies, limited human case reports
Anti-inflammatory effects are reported in animal and lab studies. There are no controlled human trials.
Safety Information
Potential Side Effects
- •Mild GI upset (oral)
Contraindications
- Pregnancy
- Breastfeeding
Interactions
- ⚠May complement anti-inflammatory medications